Nolan Mangini Siobhan 4
4 · NGM BIOPHARMACEUTICALS INC · Filed Feb 3, 2021
Insider Transaction Report
Form 4
Nolan Mangini Siobhan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-08-03+300,000→ 300,000 totalExercise: $18.88Exp: 2030-08-02→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest over a four-year period, with 1/4th vesting on July 13, 2021 and the remainder vesting in 36 equal monthly installments thereafter.